Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Clinical trial NCT06036602 · COMPLETED

Trial details

NCT number: NCT06036602
Sponsor: Albert B. Sabin Vaccine Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ebola Sudan Virus Disease

Start date: 2024-07-15
Primary completion: 2025-11-08
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.